Key result
This review summarizes recent advances in the epidemiology, genetics, pathophysiological mechanisms, and management of atrial fibrillation, including antiarrhythmic drugs and ablation.
Why the study?
The molecular and cellular mechanisms underlying AF remain incompletely established, while current antiarrhythmic drugs carry significant adverse events and ablation management is suboptimal.
Answers are grounded in this paper and cite their sources.
This review provides an overview of the current understanding of atrial fibrillation mechanisms and the status of its management through drugs and ablation.
Atrial fibrillation (AF) is a very common cardiac arrhythmia with an estimated prevalence of 33.5 million patients globally. It is associated with an increased risk of death, stroke and peripheral embolism. Although genetic studies have identified a growing number of genes associated with AF, the definitive impact of these genetic findings is yet to be established. Several mechanisms, including electrical, structural and neural remodelling of atrial tissue, have been proposed to contribute to the development of AF. Despite over a century of exploration, the molecular and cellular mechanisms underlying AF have not been fully established. Current antiarrhythmic drugs are associated with a significant rate of adverse events and management of AF using ablation is not optimal, especially in cases of persistent AF. This review discusses recent advances in our understanding and management of AF, including new concepts of epidemiology, genetics and pathophysiological mechanisms. We review the current status of antiarrhythmic drug therapy for AF, new potential agents, as well as mechanism-based AF ablation. This article is part of the theme issue 'The heartbeat: its molecular basis and physiological mechanisms'.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2023) conducted a review in Atrial fibrillation. This review summarizes recent advances in the epidemiology, genetics, pathophysiological mechanisms, and management of atrial fibrillation, including antiarrhythmic drugs and ablation.
Synapse has enriched 10 related papers. Consider them for comparative context: